This announcement is a separate document:
海普瑞：深圳市海普瑞药业集团股份有限公司2022年面向专业投资者公开发行公司债券发行结果公告（以此为准）
Hypertherm: Announcement on the results of the public issuance of corporate bonds to professional investors by Shenzhen Hepry Pharmaceutical Group Co., Ltd. in 2022 (subject to this)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.